mgus and neuropathy: current understanding and unmet needs
Published 1 year ago • 2.7K plays • Length 3:20Download video MP4
Download video MP3
Similar videos
-
5:22
igm de-myelinating neuropathy as a complication of mgus and wm
-
9:25
mgus diagnosis: a step-by-step approach
-
4:39
treating mgrs and mgus with neuropathy
-
1:49
pid unmet needs: awareness, testing and diagnosis
-
3:49
the importance of correctly identifying mgus and smm in patients to prevent progression to myeloma
-
1:18
monoclonal gammopathy of unknown significance (mgus) & importance of regularly monitoring patients
-
3:26
the risk of thrombotic events in patients with mgus: an analysis from the istopmm trial
-
1:34
early detection of amyloidosis, mgus, and smoldering myeloma: single-center real-world experience
-
40:35
peripheral neuropathy and myeloma
-
6:47
al amyloidosis and a critical, early diagnosis
-
5:43
orbital meningioma
-
1:38
diagnostic and clinical impact of the revised definition of light chain mgus
-
1:26
determining the prevalence of mgus & deciphering the mechanisms of disease progression
-
1:12
the key unmet needs in the frontline and r/r setting in amyloidosis
-
2:19
hematology in focus: mgus with clinical significance
-
2:11
unmet needs in bone marrow failure syndromes & myeloid malignancies: characterization & novel agents
-
2:56
the prognostic significance of mgus-like profiles in transplant-eligible patients with myeloma
-
4:20
therapy-related all: etiology, prognosis, and treatment
-
2:38
unmet needs in imaging for the diagnosis of al amyloidosis
-
3:06
the imwg frailty score explained
-
1:41
an overview of the mds diagnosis pathway
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml